Trials / Completed
CompletedNCT02194972
Clinical Effects of Soluble Dietary Fiber Supplementation
Study of Soluble Dietary Fiber on Colonic Transit Time and Clinical Symptoms in Adults With Slow-transit Constipation
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 80 (actual)
- Sponsor
- Nanjing PLA General Hospital · Academic / Other
- Sex
- All
- Age
- 18 Years – 78 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to investigate the effect of pectin, a kind of soluble dietary fiber, on colonic transit time, clinical symptoms and the gut microbiota in adults with slow-transit constipation.
Detailed description
Patients were randomized to receive either pectin or placebo. Treatment consisted of 4 weeks supplementation with pectin (fiber group) or placebo. We evaluated the colonic transit time, constipation symptoms and fecal bacterial population in two groups.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Pectin | pectin （Andeli Ltd. Yantai, China）, 24g/d for 4weeks |
Timeline
- Start date
- 2009-05-01
- Primary completion
- 2012-10-01
- Completion
- 2012-10-01
- First posted
- 2014-07-21
- Last updated
- 2018-08-24
Source: ClinicalTrials.gov record NCT02194972. Inclusion in this directory is not an endorsement.